A royal correspondent for Vanity Fair weighs in on how the Duchess of Sussex "must feel" now following the explosive claims made by people who used to work for her.
Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that CEPI, the Coalition for Epidemic Preparedness ...